Your browser doesn't support javascript.
loading
International validation of a health-related quality-of-life questionnaire for Hodgkin lymphoma: the EORTC QLQ-HL27.
Oerlemans, Simone; Efficace, Fabio; Shamieh, Omar; Cardoso Borges, Fabio; de Jong, Corine; Dong, Dong; Lehmann, Jens; Malak, Sandra; Petranovic, Duska; Scholz, Christian W; Caocci, Giovanni; Molica, Stefano; Griskevicius, Laimonas; Nagele, Eva; Bredart, Anne; Carvalho, Elisabete; Xochelli, Aliki; Agelink van Rentergem, Joost; Alrjoob, Waleed; Mueller, Anja; Freitas, Ana Carolina; Cocks, Kim; Creutzberg, Carien; Kyriakou, Charalampia; van de Poll-Franse, Lonneke.
Afiliación
  • Oerlemans S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  • Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases Data Centre, Rome, Italy.
  • Shamieh O; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Cardoso Borges F; Faculty of Medicine, University of Jordan, Amman, Jordan.
  • de Jong C; Department of Epidemiology and National Cancer Registry, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal.
  • Dong D; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Lehmann J; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Malak S; University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
  • Petranovic D; Hôpital René Huguenin-Institut Curie- Hématologie, Saint-Cloud, France.
  • Scholz CW; Clinical Hospital Center Rijeka, University of Rijeka, Rijeka, Croatia.
  • Caocci G; Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany.
  • Molica S; Hematology, Businco Hospital, University of Cagliari, Cagliari, Italy.
  • Griskevicius L; Azienda Ospedalier Ciaccio, Catanzaro, Italy.
  • Nagele E; Hematology, Oncology and Transfusion Medicine, Vilnius University Hospital Santaros Klinikos and Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Bredart A; Medical University of Graz, Graz, Austria.
  • Carvalho E; Institut Curie Psycho-Oncology Unit; Paris University, Psychopathology and Health Process Laboratory (UR 4057); PSL University, Paris, France.
  • Xochelli A; Department of Epidemiology and National Cancer Registry, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal.
  • Agelink van Rentergem J; Clinical Research Unit, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal.
  • Alrjoob W; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
  • Mueller A; Department of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Freitas AC; Department of Palliative Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Cocks K; Hematology and Oncology, Vivantes Klinikum Am Urban, Berlin, Germany.
  • Creutzberg C; Hematology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon, Portugal.
  • Kyriakou C; York Trials Unit, University of York, York & Adelphi Values, Cheshire, United Kingdom.
  • van de Poll-Franse L; Department of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Blood Adv ; 7(22): 7045-7055, 2023 11 28.
Article en En | MEDLINE | ID: mdl-37738090
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedad de Hodgkin Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Enfermedad de Hodgkin Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos